The invention provides 3 -deuterium-enriched 3-(5-substituted-4-oxoquinazolin-3(4H)- yl)- piperidine-2,6-diones, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same, such as in the treatment of cancer, an immune-related disease, or an inflammatory disease.